Expand EVAX Menu
EVAX MENU

EVAX Latest Press Releases

-- February 25, 2025 --

Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package Globe Newswire 8:00 AM

-- February 14, 2025 --

Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination Globe Newswire 8:00 AM

-- January 31, 2025 --

Evaxion announces closing of $10.8 million public offering Globe Newswire 4:05 PM

-- January 30, 2025 --

Evaxion announces pricing of $10.8 million public offering Globe Newswire 8:00 AM

-- January 28, 2025 --

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement Globe Newswire 8:15 AM

-- January 15, 2025 --

Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01 Globe Newswire 8:00 AM

-- January 14, 2025 --

Evaxion announces completion of ADS ratio change Globe Newswire 4:05 PM

-- January 10, 2025 --

Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change Globe Newswire 8:00 AM

-- December 30, 2024 --

Evaxion announces plan to implement ADS ratio change Globe Newswire 8:00 AM

-- December 17, 2024 --

Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity Globe Newswire 8:00 AM

-- December 12, 2024 --

Evaxion establishes new AI-derived precision cancer vaccine concept Globe Newswire 8:00 AM

-- December 9, 2024 --

Evaxion announces 2025 milestones reflecting continued strong strategy execution Globe Newswire 8:00 AM

-- December 2, 2024 --

Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress Globe Newswire 8:00 AM

-- November 13, 2024 --

Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing Globe Newswire 8:00 AM

-- November 12, 2024 --

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1 Globe Newswire 8:00 AM

-- October 31, 2024 --

Evaxion announces business update and third quarter 2024 financial results Globe Newswire 8:00 AM

-- October 28, 2024 --

Evaxion to announce business update and third quarter 2024 financial results on October 31 Globe Newswire 8:00 AM

-- October 9, 2024 --

Strong validation of Evaxion's AI-Immunology platform in multiple clinical trials Globe Newswire 8:00 AM

-- October 3, 2024 --

Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology platform Globe Newswire 8:00 AM